|Subject:||Markets expected to open higher|
|Date:||Fri, 07 May 2004 07:28:37 +0000|
(OTC PINK SHEETS: BIEL)
**MEGA TRADING ALERT**
Check out the gains from recent strong-buy recommendations...
December?HTSC at .70 High 3.25....410% Gain!
January?...QLHC at 90 High 3.50....389% Gain!
April ??.....IPYS at .30 High 1.10.....266% in two days
These types of gains
happen every day in the world of Pink sheets! Lets look at today's
featured company: Bioelectronics Corp.
Bioelectronics Corp: BIEL
Reasons to buy BIEL.PK : BIEL (Bioelectronics Corporation) is taking proven medical technologies and making them available to more people in new convenient, cost-effective dermal patches. By applying advanced microelectronic technology, Bioelectronics is dramatically reducing the size and the cost of some well-establ
BIEL first FDA cleared product, ACTIPATCH (TM) therapy is a dermal patch with an embedded microchip that delivers weeks of continuous pulsed electromagnetic energy. ActiPatch therapy is the miniaturized equivalent of the large pulsed electromagnetic energy machines prescribed by physicians for decades to reduce swelling, relieve pain and enhance the healing of surgical incisions, accidental wounds, sprains, strains and chronic wounds (bedsores). ActiPatch's size, portability, ease of use and relatively low price overcomes the obstacles to use associated with the large, expensive, stationary machines. The introduction of ActiPatch provides an immediate therapeutic alternative for the 200 million surgical and non-surgical soft tissue injuries across the U.S. annually. BioElectronics has launched it's ActiPatch product line in cooperative distribution relationships with several well-established medical device companies in various medical market segments.
New Products and Additional Applications: BIEL and leading pharmaceutical and device manufacturers and conducting new clinical trials. These trials include: Abdominoplasty -- pain; Face and Forehead Lifts -- pain and edema, Facial Fat Injections -- pain and edema; Heel -- pain and healing; Oral Surgery -- pain; Swelling and accelerated healing; and Abdominal Surgery -- pain and accelerated healing. Successful results in these trials will be published and used to secure additional FDA approved indications of use.
BIEL is developing
products for the treatment of chronic pain, arthritis, inflammatory skin
conditions, and chronic wounds.
In compliance with Section 17(b), we disclose the holding
of independently purchased shares of the company mentioned prior to the
publication of this report.. Be aware of an inherent conflict of
interest resulting from such holdings due to our intent to profit from
the liquidation of these shares. Shares may be sold at any time, even
after positive statements have been made regarding the above company.
Short term trading targets are only guesses on our part. Keep in mind
that when trading small stocks like the company above there is a chance
you will lose every penny you invest. Furthermore there have been times
in the past when the Company itself tells lies, gives false information
and puts out false news. This email is for entertainment purposes only.
This is not investment advice. We suggest you check with an investment
professional before investing any stocks or mutual funds.
|[Prev in Thread]||Current Thread||[Next in Thread]|